Physiological roles of the permeability transition pore

Circulation Research

Volumn 111, Issue 9, 2012, Pages 1237-1247

  Brenner, Catherine ^a,b   Moulin, Maryline ^a,b  

^a Universite Paris Sud   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

calcium; cell death; channel; cyclosporin A; metabolism

Indexed keywords

MITOCHONDRIAL PERMEABILITY TRANSITION PORE;

BIOCHEMICAL COMPOSITION; BIOGENESIS; BIOPHYSICS; CALCIUM TRANSPORT; CELL METABOLISM; GENETICS; HEART DISEASE; HEART FUNCTION; HUMAN; METABOLIC REGULATION; MITOPHAGY; NONHUMAN; PHENOTYPE; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; CALCIUM; DISEASE MODELS, ANIMAL; HEART; HOMEOSTASIS; HUMANS; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS;

EID: 84867722747     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.112.265942     Document Type: Review

References (156)

1. Wallace DC. Mitochondrial diseases in man and mouse. Science. 1999;283:1482-1488.
2. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabi-lization in cell death. Physiol Rev. 2007;87:99-163. (Pubitemid 46209992)
3. Hunter DR, Haworth RA, Southard JH. Relationship between confgura-tion, function, and permeability in calcium-treated mitochondria. J Biol Chem. 1976;251:5069-5077.
4. Duchen MR, McGuinness O, Brown LA, Crompton M. On the involvement of a cyclosporin A sensitive mitochondrial pore in myocardial reperfusion injury. Cardiovasc Res. 1993;27:1790-1794. (Pubitemid 23337871)
5. Griffths EJ, Halestrap AP. Mitochondrial non-specifc pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J. 1995;307 (Pt 1):93-98.
6. Bernardi P. The permeability transition pore. Control points of a cyclo-sporin A-sensitive mitochondrial channel involved in cell death. Biochim Biophys Acta. 1996;1275:5-9. (Pubitemid 26233155)
7. Lemasters JJ, Nieminen AL, Qian T, Trost LC, Herman B. The mito-chondrial permeability transition in toxic, hypoxic and reperfusion injury. Mol Cell Biochem. 1997;174:159-165. (Pubitemid 27404184)
8. Marzo I, Brenner C, Zamzami N, Susin SA, Beutner G, Brdiczka D, Rémy R, Xie ZH, Reed JC, Kroemer G. The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins. J Exp Med. 1998;187:1261-1271. (Pubitemid 28189115)
9. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res. 2004;61:372-385. (Pubitemid 38210145)
10. Tatton WG, Olanow CW. Apoptosis in neurodegenerative diseases: the role of mitochondria. Biochim Biophys Acta. 1999;1410:195-213. (Pubitemid 29078605)
11. Elrod JW, Wong R, Mishra S, Vagnozzi RJ, Sakthievel B, Goonasekera SA, Karch J, Gabel S, Farber J, Force T, Brown JH, Murphy E, Molkentin JD. Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic fexibility, and propensity for heart failure in mice. J Clin Invest. 2010;120:3680-3687.
12. Griffths EJ, Halestrap AP. Protection by Cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts. J Mol Cell Cardiol. 1993;25:1461-1469. (Pubitemid 24049454)
13. Piot C, Croisille P, Staat P, Thibault H, et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med. 2008;359:473-481.
14. Petronilli V, Miotto G, Canton M, Brini M, Colonna R, Bernardi P, Di Lisa F. Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fuorescence. Biophys J. 1999;76:725-734. (Pubitemid 29264555)
15. Lemasters JJ, Qian T, Trost LC, Herman B, Cascio WE, Bradham CA, Brenner DA, Nieminen AL. Confocal microscopy of the mitochondrial permeability transition in necrotic and apoptotic cell death. Biochem Soc Symp. 1999;66:205-222. (Pubitemid 129639033)
16. Korge P, Weiss JN. Thapsigargin directly induces the mitochondrial permeability transition. Eur J Biochem. 1999;265:273-280. (Pubitemid 29466036)
17. Jacotot E, Ravagnan L, Loeffer M, et al. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J Exp Med. 2000;191:33-46.
18. Blattner JR, He L, Lemasters JJ. Screening assays for the mitochondrial permeability transition using a fuorescence multiwell plate reader. Anal Biochem. 2001;295:220-226. (Pubitemid 32756977)
19. Belzacq-Casagrande AS, Martel C, Pertuiset C, Borgne-Sanchez A, Jacotot E, Brenner C. Pharmacological screening and enzymatic assays for apoptosis. Front Biosci. 2009;14:3550-3562.
20. Uribe-Carvajal S, Luévano-Martínez LA, Guerrero-Castillo S, Cabrera-Orefce A, Corona-de-la-Peña NA, Gutiérrez-Aguilar M. Mitochondrial Unselective Channels throughout the eukaryotic domain. Mitochondrion. 2011;11:382-390.
21. Brdiczka D. Contact sites between mitochondrial envelope membranes. Structure and function in energy-and protein-transfer. Biochim Biophys Acta. 1991;1071:291-312. (Pubitemid 121002415)
22. Vyssokikh MY, Brdiczka D. The function of complexes between the outer mitochondrial membrane pore (VDAC) and the adenine nucleo-tide translocase in regulation of energy metabolism and apoptosis. Acta Biochim Pol. 2003;50:389-404. (Pubitemid 37034693)
23. Nieminen AL, Petrie TG, Lemasters JJ, Selman WR. Cyclosporin A delays mitochondrial depolarization induced by N-methyl-D-aspartate in cortical neurons: evidence of the mitochondrial permeability transition. Neuroscience. 1996;75:993-997. (Pubitemid 26377087)
24. Pastorino JG, Simbula G, Yamamoto K, Glascott PA Jr, Rothman RJ, Farber JL. The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. J Biol Chem. 1996;271:29792-29798. (Pubitemid 26389609)
25. Gogvadze V, Robertson JD, Zhivotovsky B, Orrenius S. Cytochrome c release occurs via Ca2+-dependent and Ca2+-independent mechanisms that are regulated by Bax. J Biol Chem- 1996;276:19066-s.
26. Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A, Haeffner A, Hirsch F, Geuskens M, Kroemer G. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med. 1996;184:1155-1160. (Pubitemid 26313572)
27. Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT, Thompson CB. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell. 1997;91:627-637. (Pubitemid 27513654)
28. Di Lisa F, Menabò R, Canton M, Barile M, Bernardi P. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem. 2001;276:2571-2575.
29. Kim JS, He L, Qian T, Lemasters JJ. Role of the mitochondrial permeability transition in apoptotic and necrotic death after ischemia/reperfu-sion injury to hepatocytes. Curr Mol Med. 2003;3:527-535. (Pubitemid 37173382)
30. Zamzami N, El Hamel C, Maisse C, Brenner C, Muñoz-Pinedo C, Belzacq AS, Costantini P, Vieira H, Loeffer M, Molle G, Kroemer G. Bid acts on the permeability transition pore complex to induce apoptosis. Oncogene. 2000;19:6342-6350. (Pubitemid 32641848)
31. Martel C, Huynh L, Garnier A, Ventura-Clapier R, Brenner C. Inhibition of the mitochondrial permeability transition for cytoprotection: direct versus indirect mechanisms. Biochem Res Int- 2012:1-13.
32. Vaseva AV, Marchenko ND, Ji K, Tsirka SE, Holzmann S, Moll UM. p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell. 2012;149:1536-1548.
33. Sadoshima J. Sirt3 targets mPTP and prevents aging in the heart. Aging (Albany NY). 2011;3:12-13.
34. Schönfeld P, Wieckowski MR, Wojtczak L. Long-chain fatty acid-promoted swelling of mitochondria: further evidence for the protonophoric effect of fatty acids in the inner mitochondrial membrane. FEBS Lett. 2000;471:108-112. (Pubitemid 30173303)
35. Marcil M, Bourduas K, Ascah A, Burelle Y. Exercise training induces respiratory substrate-specifc decrease in Ca2+-induced permeability transition pore opening in heart mitochondria. Am J Physiol Heart Circ Physiol. 2006;290:H1549-H1557.
36. Rasola A, Sciacovelli M, Pantic B, Bernardi P. Signal transduction to the permeability transition pore. FEBS Lett. 2010;584:1989-1996.
37. Elliott MA, Ford SJ, Prasad E, Dick LJ, Farmer H, Hogg PJ, Halbert GW. Pharmaceutical development of the novel arsenical based cancer therapeutic GSAO for Phase I clinical trial. Int J Pharm. 2012;426:67-75.
38. Park D, Chiu J, Perrone GG, Dilda PJ, Hogg PJ. The tumour metabolism inhibitors GSAO and PENAO react with cysteines 57 and 257 of mitochondrial adenine nucleotide translocase. Cancer Cell Int. 2012;12:11.
39. Hunter DR, Haworth RA. The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms. Arch Biochem Biophys. 1979;195:453-459.
40. Jones S, Martel C, Belzacq-Casagrande AS, Brenner C, Howl J. Mitoparan and target-selective chimeric analogues: membrane translocation and intracellular redistribution induces mitochondrial apoptosis. Biochim Biophys Acta. 2008;1783:849-863.
41. Pfeiffer DR, Gudz TI, Novgorodov SA, Erdahl WL. The peptide masto-paran is a potent facilitator of the mitochondrial permeability transition. J Biol Chem. 1995;270:4923-4932.
42. Jacotot E, Ferri KF, El Hamel C, et al. Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2. J Exp Med. 2001;193:509-519. (Pubitemid 32524481)
43. Vignais PV, Vignais PM, Defaye G. Adenosine diphosphate translocation in mitochondria. Nature of the receptor site for carboxyatractyloside (gummiferin). Biochemistry. 1973;12:1508-1519.
44. Costantini P, Belzacq AS, Vieira HL, Larochette N, de Pablo MA, Zamzami N, Susin SA, Brenner C, Kroemer G. Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis. Oncogene. 2000;19:307-314. (Pubitemid 30077228)
45. Vieira HL, Belzacq AS, Haouzi D, Bernassola F, Cohen I, Jacotot E, Ferri KF, El Hamel C, Bartle LM, Melino G, Brenner C, Goldmacher V, Kroemer G. The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal. Oncogene. 2001;20:4305-4316. (Pubitemid 32726872)
46. Petronilli V, Costantini P, Scorrano L, Colonna R, Passamonti S, Bernardi P. The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols. Increase of the gating potential by oxidants and its reversal by reducing agents. J Biol Chem. 1994;269:16638-16642.
47. Brenner C, Grimm S. The permeability transition pore complex in cancer cell death. Oncogene. 2006;25:4744-4756. (Pubitemid 44192088)
48. Halestrap AP, Brenner C. The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. Curr Med Chem. 2003;10:1507-1525. (Pubitemid 36896553)
49. Lauquin G, Brandolin G, Vignais P. Aryl-azido atractylosides as photoaf-fnity labels for the mitochondrial adenine nucleotide carrier. FEBS Lett. 1976;67:306-311.
50. Lauquin GJ, Vignais PV. Interaction of (3H) bongkrekic acid with the mitochondrial adenine nucleotide translocator. Biochemistry. 1976;15:2316-2322.
51. Cesura AM, Pinard E, Schubenel R, Goetschy V, Friedlein A, Langen H, Polcic P, Forte MA, Bernardi P, Kemp JA. The voltage-dependent anion channel is the target for a new class of inhibitors of the mitochondrial permeability transition pore. J Biol Chem. 2003;278:49812-49818. (Pubitemid 37548815)
52. Leung AW, Varanyuwatana P, Halestrap AP. The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition. J Biol Chem. 2008;283:26312-26323.
53. Fontaine E, Eriksson O, Ichas F, Bernardi P. Regulation of the permeability transition pore in skeletal muscle mitochondria. Modulation By electron fow through the respiratory chain complex i. J Biol Chem. 1998;273:12662-12668. (Pubitemid 28240645)
54. Davidson AM, Halestrap AP. Partial inhibition by cyclosporin A of the swelling of liver mitochondria in vivo and in vitro induced by sub-mi-cromolar [Ca2+], but not by butyrate. Evidence for two distinct swelling mechanisms. Biochem J. 1990;268:147-152. (Pubitemid 20166663)
55. Clarke SJ, McStay GP, Halestrap AP. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A. J Biol Chem. 2002;277:34793-34799.
56. Tiepolo T, Angelin A, Palma E, Sabatelli P, Merlini L, Nicolosi L, Finetti F, Braghetta P, Vuagniaux G, Dumont JM, Baldari CT, Bonaldo P, Bernardi P. The cyclophilin inhibitor Debio 025 normalizes mitochondrial function, muscle apoptosis and ultrastructural defects in Col6a1-/-myopathic mice. Br J Pharmacol. 2009;157:1045-1052.
57. Azzolin L, Antolini N, Calderan A, Ruzza P, Sciacovelli M, Marin O, Mammi S, Bernardi P, Rasola A. Antamanide, a derivative of Amanita phalloides, is a novel inhibitor of the mitochondrial permeability transition pore. PLoS ONE. 2011;6:e16280.
58. Thinnes FP, Flörke H, Winkelbach H, Stadtmüller U, Heiden M, Karabinos A, Hesse D, Kratzin HD, Fleer E, Hilschmann N. Channel active mammalian porin, purifed from crude membrane fractions of human B lymphocytes or bovine skeletal muscle, reversibly binds the stilbene-disulfonate group of the chloride channel blocker DIDS. Biol Chem Hoppe Seyler. 1994;375:315-322. (Pubitemid 2089188)
59. Gincel D, Silberberg SD, Shoshan-Barmatz V Modulation of the voltage-dependent anion channel (VDAC) by glutamate. J Bioenerg Biomembr. 2000;32:571-583. (Pubitemid 32204234)
60. Bordet T, Buisson B, Michaud M, et al. Identifcation and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis. J Pharmacol Exp Ther. 2007;322:709-720. (Pubitemid 47105813)
61. Schaller S, Paradis S, Ngoh GA, Assaly R, Buisson B, Drouot C, Ostuni MA, Lacapere JJ, Bassissi F, Bordet T, Berdeaux A, Jones SP, Morin D, Pruss RM. TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition. J Pharmacol Exp Ther. 2010;333:696-706.
62. Elimadi A, Jullien V, Tillement JP, Morin D. S-15176 inhibits mitochondrial permeability transition via a mechanism independent of its antioxidant properties. Eur J Pharmacol. 2003;468:93-101. (Pubitemid 36556252)
63. Deniaud A, Sharaf el dein O, Maillier E, Poncet D, Kroemer G, Lemaire C, Brenner C. Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis. Oncogene. 2008;27:285-299.
64. Morin D, Assaly R, Paradis S, Berdeaux A. Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection. Curr Med Chem. 2009;16:4382-4398.
65. Benjamin F, Rodrigue R, Aurelien D, Christophe R, Stephane C, Monique M, Catherine B, Thierry L. The respiratory-dependent assembly of ANT1 differentially regulates Bax and Ca2+ mediated cytochrome c release. Front Biosci (Elite Ed). 2011;3:395-409.
66. Verrier F, Deniaud A, Lebras M, Métivier D, Kroemer G, Mignotte B, Jan G, Brenner C. Dynamic evolution of the adenine nucleotide translocase interactome during chemotherapy-induced apoptosis. Oncogene. 2004;23:8049-8064. (Pubitemid 39531846)
67. Leist M, Single B, Castoldi AF, Kühnle S, Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med. 1997;185:1481-1486. (Pubitemid 27187604)
68. Nicotera P, Orrenius S. The role of calcium in apoptosis. Cell Calcium. 1998;23:173-180. (Pubitemid 28188002)
69. Kim JS, He L, Lemasters JJ. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem Biophys Res Commun. 2003;304:463-470. (Pubitemid 36506518)
70. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol. 2010;11:700-714.
71. Christof ferson DE, Yuan J. Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol. 2010;22:263-268.
72. Galluzzi L, Vitale I, Abrams JM, et al. Molecular defnitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 2012;19:107-120.
73. Oerlemans MI, Liu J, Arslan F, den Ouden K, van Middelaar BJ, Doevendans PA, Sluijter JP Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo. Basic Res Cardiol. 2012;107:270.
74. Petronilli V, Szabò I, Zoratti M. The inner mitochondrial membrane contains ion-conducting channels similar to those found in bacteria. FEBS Lett. 1989;259:137-143. (Pubitemid 20009965)
75. Zoratti M, Szabó I. Electrophysiology of the inner mitochondrial membrane. J Bioenerg Biomembr. 1994;26:543-553. (Pubitemid 24378757)
76. Zorov DB, Kinnally KW, Tedeschi H. Voltage activation of heart inner mitochondrial membrane channels. J Bioenerg Biomembr. 1992;24:119-124.
77. Zoratti M, De Marchi U, Biasutto L, Szabò I. Electrophysiology clarifes the megariddles of the mitochondrial permeability transition pore. FEBS Lett. 2010;584:1997-2004.
78. Pereira C, Camougrand N, Manon S, Sousa MJ, Côrte-Real M. ADP/ATP carrier is required for mitochondrial outer membrane permeabi-lization and cytochrome c release in yeast apoptosis. Mol Microbiol. 2007;66:571-582. (Pubitemid 47621847)
79. Zhivotovsky B, Galluzzi L, Kepp O, Kroemer G. Adenine nucleotide translocase: a component of the phylogenetically conserved cell death machinery. Cell Death Differ- 2009;16:1419-1425.
80. Woodfeld K, Rück A, Brdiczka D, Halestrap AP Direct demonstration of a specifc interaction between cyclophilin-D and the adenine nucleotide translocase confrms their role in the mitochondrial permeability transition. Biochem J. 1998;336 (Pt 2):287-290. (Pubitemid 28564382)
81. Crompton M, Virji S, Ward JM. Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. Eur J Biochem. 1998;258:729-735. (Pubitemid 28557940)
82. Brustovetsky N, Klingenberg M. Mitochondrial ADP/ATP carrier can be reversibly converted into a large channel by Ca2+. Biochemistry. 1996;35:8483-8488. (Pubitemid 26240181)
83. Rück A, Dolder M, Wallimann T, Brdiczka D. Reconstituted adenine nucleotide translocase forms a channel for small molecules comparable to the mitochondrial permeability transition pore. FEBS Lett. 1998;426:97-101. (Pubitemid 28198163)
84. Marzo I, Brenner C, Kroemer G. The central role of the mitochondrial megachannel in apoptosis: evidence obtained with intact cells, isolated mitochondria, and purifed protein complexes. Biomed Pharmacother. 1998;52:248-251. (Pubitemid 28387037)
85. Marzo I, Brenner C, Zamzami N, Jürgensmeier JM, Susin SA, Vieira HL, Prévost MC, Xie Z, Matsuyama S, Reed JC, Kroemer G. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science. 1998;281:2027-2031. (Pubitemid 28475490)
86. Brenner C, Marzo I, de Araujo Vieira HL, Kroemer G. Purifcation and liposomal reconstitution of permeability transition pore complex. Meth Enzymol. 2000;322:243-252. (Pubitemid 30482061)
87. Beutner G, Ruck A, Riede B, Welte W, Brdiczka D. Complexes between kinases, mitochondrial porin and adenylate translocator in rat brain resemble the permeability transition pore. FEBS Lett. 1996;396:189-195. (Pubitemid 26377822)
88. Brenner C, Subramaniam K, Pertuiset C, Pervaiz S. Adenine nucleotide translocase family: four isoforms for apoptosis modulation in cancer. Oncogene. 2011;30:883-895.
89. Bauer MK, Schubert A, Rocks O, Grimm S. Adenine nucleotide translocase-1, a component of the permeability transition pore, can dominantly induce apoptosis. J Cell Biol. 1999;147:1493-1502.
90. Schubert A, Grimm S. Cyclophilin D, a component of the permeability transition-pore, is an apoptosis repressor. Cancer Res. 2004;64:85-93. (Pubitemid 38114085)
91. Zamora M, Granell M, Mampel T, Viñas O. Adenine nucleotide translocase 3 (ANT3) overexpression induces apoptosis in cultured cells. FEBS Lett. 2004;563:155-160. (Pubitemid 38471591)
92. Zamora M, Meroño C, Viñas O, Mampel T Recruitment of NF-kappaB into mitochondria is involved in adenine nucleotide translocase 1 (ANT1)-induced apoptosis. J Biol Chem. 2004;279:38415-38423. (Pubitemid 39295992)
93. Gallerne C, Touat Z, Chen ZX, Martel C, Mayola E, Sharaf el dein O, Buron N, Le Bras M, Jacotot E, Borgne-Sanchez A, Lemoine A, Lemaire C, Pervaiz S, Brenner C. The fourth isoform of the adenine nucleotide translocator inhibits mitochondrial apoptosis in cancer cells. Int J Biochem Cell Biol. 2010;42:623-629.
94. Wang Y, Ebermann L, Sterner-Kock A, Wika S, Schultheiss HP, Dörner A, Walther T Myocardial overexpression of adenine nucleotide translocase 1 ameliorates diabetic cardiomyopathy in mice. Exp Physiol. 2009;94:220-227.
95. Narita M, Shimizu S, Ito T, Chittenden T, Lutz RJ, Matsuda H, Tsujimoto Y Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc Natl Acad Sci USA. 1998;95:14681-14686. (Pubitemid 29003690)
96. Shimizu S, Matsuoka Y, Shinohara Y, Yoneda Y, Tsujimoto Y Essential role of voltage-dependent anion channel in various forms of apoptosis in mammalian cells. J Cell Biol. 2001;152:237-250. (Pubitemid 34285595)
97. Gatliff J, Campanella M. The 18 kDa translocator protein (TSPO): a new perspective in mitochondrial biology. Curr Mol Med. 2012;12:356-368.
98. Meinecke M, Wagner R, Kovermann P, Guiard B, Mick DU, Hutu DP, Voos W, Truscott KN, Chacinska A, Pfanner N, Rehling P. Tim50 maintains the permeability barrier of the mitochondrial inner membrane. Science. 2006;312:1523-1526. (Pubitemid 43865891)
99. Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, Jones DP, MacGregor GR, Wallace DC. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature. 2004;427:461-465. (Pubitemid 38168501)
100. Dolce V, Scarcia P, Iacopetta D, Palmieri F A fourth ADP/ATP carrier isoform in man: identifcation, bacterial expression, functional characterization and tissue distribution. FEBS Lett. 2005;579:633-637.
101. Brower JV, Rodic N, Seki T, Jorgensen M, Fliess N, Yachnis AT, McCarrey JR, Oh SP, Terada N. Evolutionarily conserved mammalian adenine nucleotide translocase 4 is essential for spermatogenesis. J Biol Chem. 2007;282:29658-29666. (Pubitemid 350043375)
102. Graham BH, Waymire KG, Cottrell B, Trounce IA, MacGregor GR, Wallace DC. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a defciency in the heart/muscle isoform of the adenine nucleotide translocator. Nat Genet. 1997;16:226-234. (Pubitemid 27280204)
103. Forte A, Cipollaro M, Cascino A, Galderisi U. Small interfering RNAs and antisense oligonucleotides for treatment of neurological diseases. Curr Drug Targets. 2005;6:21-29. (Pubitemid 40394320)
104. Lee J, Schriner SE, Wallace DC. Adenine nucleotide translocator 1 defciency increases resistance of mouse brain and neurons to excitotoxic insults. Biochim Biophys Acta. 2009;1787:364-370.
105. Wallace DC, MacGregor G, Waymire KG, Levy SE, Sligh JE, Kokoszka JE. ANT2 conditional knockout mouse and methods. Patent US2008/0268445. 2008:1-13.
106. Brower J, Lim C, Jorgensen M, Oh S, Terada N. Adenine nucleotide translocase 4 defciency leads to early meiotic arrest of murine male germ cells. Biochim Biophys Acta- 2009;1789:198-203.
107. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ. Bcl-2-defcient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hy-popigmented hair. Cell. 1993;75:229-240. (Pubitemid 23320287)
108. Motoyama N, Wang F, Roth KA, Sawa H, Nakayama K, Nakayama K, Negishi I, Senju S, Zhang Q, Fujii S. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-defcient mice. Science. 1995;267:1506-1510.
109. Rinkenberger JL, Horning S, Klocke B, Roth K, Korsmeyer SJ. Mcl-1 defciency results in peri-implantation embryonic lethality. Genes Dev. 2000;14:23-27. (Pubitemid 30051575)
110. Roset R, Ortet L, Gil-Gomez G. Role of Bcl-2 family members on apoptosis: what we have learned from knock-out mice. Front Biosci. 2007;12:4722-4730.
111. Saupe KW, Spindler M, Tian R, Ingwall JS. Impaired cardiac energetics in mice lacking muscle-specifc isoenzymes of creatine kinase. Circ Res. 1998;82:898-907. (Pubitemid 28234581)
112. Basso E, Fante L, Fowlkes J, Petronilli V, Forte MA, Bernardi P. Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. J Biol Chem. 2005;280:18558-18561. (Pubitemid 41379552)
113. Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H, Inohara H, Kubo T, Tsujimoto Y. Cyclophilin D-dependent mitochon-drial permeability transition regulates some necrotic but not apoptotic cell death. Nature. 2005;434:652-658. (Pubitemid 40488558)
114. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, Brunskill EW, Sayen MR, Gottlieb RA, Dorn GW, Robbins J, Molkentin JD. Loss of cyclophilin D reveals a critical role for mitochon-drial permeability transition in cell death. Nature. 2005;434:658-662. (Pubitemid 40488559)
115. Heikkinen S, Pietilä M, Halmekytö M, Suppola S, Pirinen E, Deeb SS, Jänne J, Laakso M. Hexokinase II-defcient mice. Prenatal death of homozygotes without disturbances in glucose tolerance in heterozygotes. J Biol Chem. 1999;274:22517-22523.
116. Wu R, Wyatt E, Chawla K, Tran M, Ghanefar M, Laakso M, Epting CL, Ardehali H. Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS production. EMBO Mol Med. 2012;4:633-646.
117. Wu R, Smeele KM, Wyatt E, Ichikawa Y, Eerbeek O, Sun L, Chawla K, Hollmann MW, Nagpal V, Heikkinen S, Laakso M, Jujo K, Wasserstrom JA, Zuurbier CJ, Ardehali H. Reduction in hexokinase II levels results in decreased cardiac function and altered remodeling after ischemia/reper-fusion injury. Circ Res. 2011;108:60-69.
118. Varanyuwatana P, Halestrap AP. The roles of phosphate and the phosphate carrier in the mitochondrial permeability transition pore. Mitochondrion. 2012;12:120-125.
119. Papadopoulos V, Widmaier EP, Amri H, Zilz A, Li H, Culty M, Castello R, Philip GH, Sridaran R, Drieu K. In vivo studies on the role of the peripheral benzodiazepine receptor (PBR) in steroidogenesis. Endocr Res. 1998;24:479-487. (Pubitemid 29016428)
120. Raghavan A, Sheiko T, Graham BH, Craigen WJ. Voltage-dependant anion channels: Novel insights into isoform function through genetic models. Biochim Biophys Acta. 2012;1818:1477-1485.
121. Krauskopf A, Eriksson O, Craigen WJ, Forte MA, Bernardi P. Properties of the permeability transition in VDAC1(-/-) mitochondria. Biochim Biophys Acta. 2006;1757:590-595. (Pubitemid 43993836)
122. Anfous K, Armstrong DD, Craigen WJ. Altered mitochondrial sensitivity for ADP and maintenance of creatine-stimulated respiration in oxidative striated muscles from VDAC1-defcient mice. J Biol Chem. 2001;276:1954-1960. (Pubitemid 32109673)
123. Okada SF, O'Neal WK, Huang P, Nicholas RA, Ostrowski LE, Craigen WJ, Lazarowski ER, Boucher RC. Voltage-dependent anion channel-1 (VDAC-1) contributes to ATP release and cell volume regulation in mu-rine cells. J Gen Physiol. 2004;124:513-526. (Pubitemid 39506287)
124. Cheng EH, Sheiko T V, Fisher JK, Craigen WJ, Korsmeyer SJ. VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science. 2003;301:513-517. (Pubitemid 36900308)
125. Sampson MJ, Decker WK, Beaudet AL, Ruitenbeek W, Armstrong D, Hicks MJ, Craigen WJ. Immotile sperm and infertility in mice lacking mitochondrial voltage-dependent anion channel type 3. J Biol Chem. 2001;276:39206-39212.
126. Baines CP, Kaiser RA, Sheiko T, Craigen WJ, Molkentin JD. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol. 2007;9:550-555. (Pubitemid 46696536)
127. De Marchi U, Basso E, Szabò I, Zoratti M. Electrophysiological characterization of the Cyclophilin D-deleted mitochondrial permeability transition pore. Mol Membr Biol. 2006;23:521-530. (Pubitemid 44837737)
128. De Marchi U, Campello S, Szabò I, Tombola F, Martinou JC, Zoratti M. Bax does not directly participate in the Ca(2+)-induced permeability transition of isolated mitochondria. J Biol Chem. 2004;279:37415-37422.
129. Kass GE, Juedes MJ, Orrenius S. Cyclosporin A protects hepatocytes against prooxidant-induced cell killing. A study on the role of mitochondri-al Ca2+ cycling in cytotoxicity. Biochem Pharmacol. 1992;44:1995-2003.
130. Altschuld RA, Hohl CM, Castillo LC, Garleb AA, Starling RC, Brierley GP. Cyclosporin inhibits mitochondrial calcium effux in isolated adult rat ventricular cardiomyocytes. Am J Physiol. 1992;262:H1699-H1704.
131. Ichas F, Jouaville LS, Mazat J P. Mitochondria are excitable organelles capable of generating and conveying electrical and calcium signals. Cell. 1997;89:1145-1153. (Pubitemid 127678747)
132. Ichas F, Mazat JP. From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low-to high-conductance state. Biochim Biophys Acta. 1998;1366:33-50. (Pubitemid 28467021)
133. Chalmers S, Nicholls DG. The relationship between free and total calcium concentrations in the matrix of liver and brain mitochondria. J Biol Chem. 2003;278:19062-19070. (Pubitemid 36799293)
134. Di Lisa F, Bernardi P. Mitochondrial function and myocardial aging. A critical analysis of the role of permeability transition. Cardiovasc Res. 2005;66:222-232. (Pubitemid 40471037)
135. Youle RJ, van der Bliek AM. Mitochondrial fssion, fusion, and stress. Science. 2012;337:1062-1065.
136. Rapizzi E, Pinton P, Szabadkai G, Wieckowski MR, Vandecasteele G, Baird G, Tuft RA, Fogarty KE, Rizzuto R. Recombinant expression of the voltage-dependent anion channel enhances the transfer of Ca2+ microdomains to mitochondria. J Cell Biol. 2002;159:613-624.
137. Rizzuto R, Pozzan T. Microdomains of intracellular Ca2+: molecular determinants and functional consequences. Physiol Rev. 2006;86:369-408.
138. Deniaud A, Rossi C, Berquand A, Homand J, Campagna S, Knoll W, Brenner C, Chopineau J. Voltage-dependent anion channel transports calcium ions through biomimetic membranes. Langmuir. 2007;23:3898-3905. (Pubitemid 46581919)
139. Piquereau J, Caffn F, Novotova M, Prola A, Garnier A, Mateo P, Fortin D, Huynh le H, Nicolas V, Alavi MV, Brenner C, Ventura-Clapier R, Veksler V, Joubert F. Down-regulation of OPA1 alters mouse mitochon-drial morphology, PTP function, and cardiac adaptation to pressure over load. Cardiovasc Res. 2012;94:408-417.
140. Giralt A, Villarroya F. SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging. Biochem J. 2012;444:1-10.
141. Sundaresan NR, Samant SA, Pillai VB, Rajamohan SB, Gupta MP. SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70. Mol Cell Biol. 2008;28:6384-6401.
142. Sack MN. Emerging characterization of the role of SIRT3-mediated mi-tochondrial protein deacetylation in the heart. Am J Physiol Heart Circ Physiol. 2011;301:H2191-H2197.
143. Miura T, Tanno M. The mPTP and its regulatory proteins: fnal common targets of signalling pathways for protection against necrosis. Cardiovasc Res. 2012;94:181-189.
144. Sheldon KL, Maldonado EN, Lemasters JJ, Rostovtseva TK, Bezrukov SM. Phosphorylation of voltage-dependent anion channel by serine/threonine kinases governs its interaction with tubulin. PLoS ONE. 2011;6:e25539.
145. Pastorino JG, Hoek JB, Shulga N. Activation of glycogen synthase kinase
146. Pastorino JG, Shulga N, Hoek JB. Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem. 2002;277:7610-7618. (Pubitemid 34953160)
147. Smeele KM, Southworth R, Wu R, et al. Disruption of hexokinase II-mitochondrial binding blocks ischemic preconditioning and causes rapid cardiac necrosis. Circ Res. 2011;108:1165-1169.
148. Martel C, Allouche M, Esposti DD, Fanelli E, Boursier C, Henry C, Chopineau J, Calamita G, Kroemer G, Lemoine A, Brenner C. GSK3-mediated VDAC phosphorylation controls outer mitochon-drial membrane permeability during lipid accumulation. Hepatology. July 19, 2012. doi: 10.1002/hep.25967. http://onlinelibrary.wiley.com/doi/10.1002/hep.25967/abstract;jsessionid= 57311C38A9DA124531C7 74AAACE6D2E1.d03t03. Accessed October 1, 2012.
149. Zamzami N, Marzo I, Susin SA, Brenner C, Larochette N, Marchetti P, Reed J, Kofer R, Kroemer G. The thiol crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mito-chondrial permeability transition. Oncogene. 1998;16:1055-1063. (Pubitemid 28107943)
150. Curtis JM, Hahn WS, Long EK, Burrill JS, Arriaga EA, Bernlohr DA. Protein carbonylation and metabolic control systems. Trends Endocrinol Metab. 2012;23:399-406.
151. Queiroga CS, Almeida AS, Martel C, Brenner C, Alves PM, Vieira HL. Glutathionylation of adenine nucleotide translocase induced by carbon monoxide prevents mitochondrial membrane permeabilization and apoptosis. J Biol Chem. 2010;285:17077-17088.
152. Nguyen TT, Stevens MV, Kohr M, Steenbergen C, Sack MN, Murphy E. Cysteine 203 of cyclophilin D is critical for cyclophilin D activa tion of the mitochondrial permeability transition pore. J Biol Chem. 2011;286:40184-40192.
153. Rodriguez-Enriquez S, He L, Lemasters JJ. Role of mitochondrial permeability transition pores in mitochondrial autophagy. Int J Biochem Cell Biol. 2004;36:2463-2472. (Pubitemid 39119759)
154. He L, Lemasters JJ. Regulated and unregulated mitochondrial permeability transition pores: a new paradigm of pore structure and function? FEBS Lett. 2002;512:1-7. (Pubitemid 34164440)
155. Seidlmayer LK, Gomez-Garcia MR, Blatter LA, Pavlov E, Dedkova EN. Inorganic polyphosphate is a potent activator of the mitochon-drial permeability transition pore in cardiac myocytes. J Gen Physiol. 2012;139:321-331.
156. St John JC, Jokhi RP, Barratt CL. The impact of mitochondrial genetics on male infertility. Int J Androl. 2005;28:65-73. (Pubitemid 40461175)